Intended for healthcare professionals


Evidence does not support vitamin D for reducing respiratory infections, reviews conclude

BMJ 2020; 369 doi: (Published 30 June 2020) Cite this as: BMJ 2020;369:m2629

Read our latest coverage of the coronavirus pandemic

  1. Ingrid Torjesen
  1. London, UK

Two rapid reviews by public health agencies in England have concluded there is insufficient evidence to determine whether vitamin D supplementations could have a role in reducing the risk of respiratory tract infections, including covid-19.

Two weeks ago Public Health England commissioned the Scientific Advisory Commission on Nutrition (SACN) to examine new evidence on whether vitamin D supplementation could reduce the risk of acute respiratory tract infections and, at the same time, the National Institute for Health and Care Excellence (NICE) launched a review of emerging evidence on vitamin D and the prevention and treatment of covid-19.1

The SACN review assessed evidence on vitamin D and acute respiratory tract infections, other than covid-19, published since its last review in 2016, and concluded that the available evidence does not support vitamin D supplementation to prevent acute respiratory tract infections …

View Full Text